These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1833515

  • 1. Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury.
    Quattrocchi KB, Frank EH, Miller CH, Amin A, Issel BW, Wagner FC.
    J Neurosurg; 1991 Nov; 75(5):766-73. PubMed ID: 1833515
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors.
    Quattrocchi KB, Miller CH, Wagner FC, DeNardo SJ, DeNardo GL, Ovodov K, Frank EH.
    J Neurosurg; 1992 Nov; 77(5):694-9. PubMed ID: 1403109
    [Abstract] [Full Text] [Related]

  • 3. Impairment of helper T-cell function following severe head injury.
    Quattrocchi KB, Issel BW, Miller CH, Frank EH, Wagner FC.
    J Neurotrauma; 1992 Nov; 9(1):1-9. PubMed ID: 1377752
    [Abstract] [Full Text] [Related]

  • 4. Humoral and cellular immunity following severe head injury: review and current investigations.
    Miller CH, Quattrocchi KB, Frank EH, Issel BW, Wagner FC.
    Neurol Res; 1991 Jun; 13(2):117-24. PubMed ID: 1682838
    [Abstract] [Full Text] [Related]

  • 5. [In vitro enhancement of cytotoxicity of human peripheral blood lymphocytes with recombinant interleukin 2 and an interferon mixture (alpha + beta + gamma) against human colon carcinoma cell line SW1116].
    Kimoto Y.
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3419-26. PubMed ID: 3098183
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of cytolytic activity and cell surface phenotypes of lymphokine activated killer cells stimulated with R-IL 2 and an anti-CD 3 antibody].
    Kikuchi T, Sakai H, Nakamura N, Watanabe M, Ohno T.
    No To Shinkei; 1990 Jun; 42(6):575-80. PubMed ID: 2119634
    [Abstract] [Full Text] [Related]

  • 7. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer.
    Wanebo HJ, Blackinton D, Kouttab N, Mehta S.
    Am J Surg; 1993 Oct; 166(4):389-94. PubMed ID: 8214299
    [Abstract] [Full Text] [Related]

  • 8. Lymphokine activated killer cells and interleukin-2 production in patients with cervical carcinoma.
    De AK, Jhaver KG, Kamat MR, Nadkarni JJ.
    Neoplasma; 1991 Oct; 38(5):493-9. PubMed ID: 1835519
    [Abstract] [Full Text] [Related]

  • 9. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C, García-Pérez MJ, Ramirez R, Martín C, Alvarez MA, Martinez F, Gómez P, García-Castellano JM, Torres A.
    Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
    [Abstract] [Full Text] [Related]

  • 10. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 Dec 15; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 12. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM, Yang WK, Ting CC, Tsai WY, Yang DM, Whang-Peng J, Perng RP.
    Chest; 1997 Oct 15; 112(4):960-6. PubMed ID: 9377959
    [Abstract] [Full Text] [Related]

  • 13. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov 15; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 14. Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.
    Lamers HJ, Gratama JW, van Putten WL, Stoter G, Bolhuis RL.
    Cancer Res; 1991 May 01; 51(9):2324-8. PubMed ID: 2015597
    [Abstract] [Full Text] [Related]

  • 15. [Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2)].
    Wustrow TP.
    HNO; 1991 Sep 01; 39(9):323-31. PubMed ID: 1836210
    [Abstract] [Full Text] [Related]

  • 16. Suppression of cellular immune activity following severe head injury.
    Quattrocchi KB, Frank EH, Miller CH, MacDermott JP, Hein L, Frey L, Wagner FC.
    J Neurotrauma; 1990 Sep 01; 7(2):77-87. PubMed ID: 2376866
    [Abstract] [Full Text] [Related]

  • 17. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
    Mier JW, Brandon EP, Libby P, Janicka MW, Aronson FR.
    J Immunol; 1989 Oct 01; 143(7):2407-14. PubMed ID: 2528594
    [Abstract] [Full Text] [Related]

  • 18. Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome.
    Chin TW, Plaeger-Marshall S, Haas A, Ank BJ, Stiehm ER.
    Clin Immunol Immunopathol; 1989 Dec 01; 53(3):449-59. PubMed ID: 2509119
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
    Sugarbaker PH, Matthews W, Steller EP, Eggermont AM.
    J Biol Response Mod; 1987 Aug 01; 6(4):430-45. PubMed ID: 3498012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.